Skip to content

Insider · CIK 0001752461

Derek M Meisner

officer

Files at ABOS (Acumen Pharmaceuticals, Inc.). First filing Jan 7, 2025, latest Jan 23, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $26k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ABOS: Acumen Pharmaceuticals, Inc.

ABOSOct 9, 2026 · close 2.14

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
10Weak
ABOSsell 510b5-1
Acumen Pharmaceuticals, Inc.
$5,435
3,418 shares
-2%-
15Weak
ABOSsell 510b5-1
Acumen Pharmaceuticals, Inc.
$21k
11,122 shares
-10%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 21, 2025ABOS
Acumen Pharmaceuticals, Inc.
SOpen-market sale
Common Stock10b5-1
-3,418$1.59$5,435161,127Jan 23, 2025
Jan 3, 2025ABOS
Acumen Pharmaceuticals, Inc.
SOpen-market sale
Common Stock10b5-1
-11,122$1.84$21k97,745Jan 7, 2025
Jan 6, 2025ABOS
Acumen Pharmaceuticals, Inc.
AGrant or award
Common Stock10b5-1
+66,800$0.00$0164,545Jan 7, 2025
Jan 6, 2025ABOS
Acumen Pharmaceuticals, Inc.
AGrant or award
Employee Stock Option (right to buy)derivative10b5-1
+100,300$0.00$0100,300Jan 7, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Derek M Meisner: insider trades and track record | InsiderTell